biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > A Comment About Bankruptcy

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Aug 26, 2023 3:41pm

191 Views

Post# 35606857

RE:RE:RE:RE:A Comment About Bankruptcy

Thanks, TT-Boy.

And, no, TT-Boy, I am not on welfare. I get my pensions, a number of them, including CPP, like all Canadians do. I get OAS but that will be clawed back this year.

As a Canadian, do you qualify for CPP? Or do you benefit from offshore tax "advantages" that make up for it?

jd

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for Nov. 14, 2024